Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 85138

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 27, 2020
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
The Harvard Drug Group

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Quetiapine Fumarate Extended-Release Tablets, 50 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6801-61

D-0999-2020
Recall number
D-0999-2020
Initiated
February 27, 2020
Classification
Class III
Status
Terminated
Recalling firm
The Harvard Drug Group
Quantity
330 cartons

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling; Incorrect or Missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Code information

Lot, expiry: Lot N00028, exp 04/2021; Lot N00044, exp 06/2021

Distribution pattern

Nationwide

drug · product 2 of 4

Quetiapine Fumarate Extended-Release Tablets, 150 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6802-61

D-1000-2020
Recall number
D-1000-2020
Initiated
February 27, 2020
Classification
Class III
Status
Terminated
Recalling firm
The Harvard Drug Group
Quantity
1 carton

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling; Incorrect or Missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Code information

Lot, expiry: Lot N00036, exp 05/2021

Distribution pattern

Nationwide

drug · product 3 of 4

Quetiapine Fumarate Extended-Release Tablets, 200 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6803-61

D-1001-2020
Recall number
D-1001-2020
Initiated
February 27, 2020
Classification
Class III
Status
Terminated
Recalling firm
The Harvard Drug Group
Quantity
115 cartons

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling; Incorrect or Missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Code information

Lot, expiry: Lot N00037, exp 05/2021

Distribution pattern

Nationwide

drug · product 4 of 4

Quetiapine Fumarate Extended-Release Tablets, 300 mg, 100 tablets per unit dose carton, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.) 454775 India; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-6804-61

D-1002-2020
Recall number
D-1002-2020
Initiated
February 27, 2020
Classification
Class III
Status
Terminated
Recalling firm
The Harvard Drug Group
Quantity
Unavailable

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling; Incorrect or Missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Code information

Lot, expiry: Lot N00037, exp 05/2021

Distribution pattern

Nationwide